• 24:14 - 30:13
Breaking: Democrats Announce Plan to Forcibly Take Children From Parents For Possible Contact With Covid Carriers – FULL SHOW 9/1/21
FDA Official Statements, Bloomberg Reports, Janet Woodcock, Fentanyl Approval
Detailed reports from Bloomberg and Endpoint News confirm the exit of Marion Gruber and Phil Krause from the FDA due to the White House bypassing regulatory reviews. Acting FDA Commissioner Janet Woodcock is criticized for her past role in approving Oxycontin and Fentanyl. The administration's plan to make boosters available by September 20th is presented as a violation of statutory FDA authority.